ReWalk Robotics (NASDAQ: RWLK) and Inogen (NASDAQ:INGN) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.
Valuation & Earnings
This table compares ReWalk Robotics and Inogen’s top-line revenue, earnings per share (EPS) and valuation.
||Earnings Per Share
Inogen has higher revenue and earnings than ReWalk Robotics.
This is a summary of current ratings for ReWalk Robotics and Inogen, as provided by MarketBeat.com.
||Strong Buy Ratings
ReWalk Robotics presently has a consensus target price of $2.80, suggesting a potential upside of 161.68%. Inogen has a consensus target price of $188.75, suggesting a potential upside of 3.30%. Given ReWalk Robotics’ higher probable upside, equities research analysts plainly believe ReWalk Robotics is more favorable than Inogen.
This table compares ReWalk Robotics and Inogen’s net margins, return on equity and return on assets.
||Return on Equity
||Return on Assets
Insider and Institutional Ownership
2.5% of ReWalk Robotics shares are held by institutional investors. Comparatively, 99.4% of Inogen shares are held by institutional investors. 13.7% of ReWalk Robotics shares are held by insiders. Comparatively, 5.3% of Inogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Volatility & Risk
ReWalk Robotics has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, Inogen has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500.
Inogen beats ReWalk Robotics on 10 of the 13 factors compared between the two stocks.
ReWalk Robotics Company Profile
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It is also developing ReWalk Restore, a soft suit exoskeleton for individuals who have suffered a stroke. ReWalk Robotics Ltd. markets and sells its products directly to third party payers, institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokne'am Illit, Israel.
Inogen Company Profile
Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company's oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was founded in 2001 and is headquartered in Goleta, California.
Receive News & Ratings for ReWalk Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics and related companies with MarketBeat.com's FREE daily email newsletter.